Skip to search formSkip to main contentSkip to account menu

Hydrocortisone butyrate

Known as: 11-beta,17-alpha,21-Trihydroxy-4-pregnene-3,20-dione 17-alpha-butyrate, hydrocortisone 17-butyrate, hydrocortisone-17-butyrate 
The butyrate salt form of hydrocortisone, a synthetic glucocorticoid receptor agonist with antiinflammatory, antipruritic and vasoconstrictive… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
The cytokine interleukin‐31 (IL‐31) is considered to be responsible for the development of pruritus in humans. At present, no… 
Review
2016
Review
2016
BackgroundMany clinicians have concerns about the safety of atopic dermatitis (AD) treatments, particularly in children requiring… 
Highly Cited
2015
Highly Cited
2015
This study was conducted to develop formulations of hydrocortisone butyrate (HB)-loaded poly(d,l-lactic-co-glycolic acid… 
Highly Cited
2012
Highly Cited
2012
Background The treatment of vitiligo remains unsatisfactory. 
Highly Cited
2006
Highly Cited
2006
Background  Staphylococcus aureus has a peculiar ability to colonize the skin of patients with eczema and atopic dermatitis (AD… 
Highly Cited
2006
Highly Cited
2006
Highly Cited
2005
Highly Cited
2005
Background  Atopic dermatis (AD) is a chronic disease that often requires long‐term treatment. Topical corticosteroids are the… 
Review
2005
Review
2005
Abstract Objective To determine the efficacy and tolerability of topical pimecrolimus and tacrolimus compared with other… 
Highly Cited
2003
Highly Cited
2003
Summary Background Fexofenadine, a nonsedating, H1‐receptor selective antihistamine, exhibits consistent efficacy and safety in… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND Vehicle-controlled studies have demonstrated the efficacy and safety of tacrolimus ointment for patients with atopic…